Health Condition 1: O20-O29- Other maternal disorders predominantly related to pregnancy
Conditions
Interventions
Intervention1: Injection Iron Isomaltoside: Injection Iron Isomaltoside is a parenteral iron formulation given to correct iron deficiency anemia. It is given intravenously according to the iron defici
Sponsors
Bhawna Garg
Eligibility
Inclusion criteria
Inclusion criteria: Antepartum women whose Hemoglobin is in range of 7 to 10.9 gram per decilitre Women in second trimester of pregnancy (14- to 22 weeks)
Exclusion criteria
Exclusion criteria: Women not willing to participate Women with less than 14 weeks of gestation Women in labor Known case of Thalassemia or Megaloblastic anemia Women who have a history or known allergy to parenteral iron infusion. Women with normal serum ferritin levels history of any liver disease history of any Autoimmune disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate the efficacy (rise in Haemoglobin) of Injection Iron Isomaltoside in comparison to Injection Ferric Carboxymaltose in treating Iron deficiency anemia in pregnancy.Timepoint: at 26 to 30 weeks of gestation | — |
Secondary
| Measure | Time frame |
|---|---|
| To investigate the safety in terms of local and systemic reactions and tolerability of injection Iron Isomaltoside in comparison with injection Ferric CarboxyMaltoseTimepoint: immediately during drug administration till the period of 30 minutes | — |
Countries
India
Contacts
Public ContactBhawna Garg
Jawaharlal Nehru Medical College
Outcome results
None listed